ExploreOutcomeHAM-D insomnia subscale improvement
Outcome

HAM-D insomnia subscale improvement

Also known as: HAM-D insomnia subscale improvement HAM-D
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (27)

None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94
None
improvement

Treatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D insomnia subscale compared to nonresponders after 8 weeks of antidepressant treatment.

Effect: improvement; Cohen's d=.94

Size: Cohen's d=.94

Papers (1)